Doç. Dr. Yusuf Taha Güllü

• COVID-19 3 publications
  Source: OpenAlex / PubMed MeSHView publications

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

Experience

• Experience24.07.2024 Mudanya Üniversitesi Meslek Yüksekokulu Anestezi Pr. Tam Burslu Doçentmedicalpark.com.tr
• Experience13.10.2023-14.07.2024 Ondokuz Mayıs Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Doçentmedicalpark.com.tr
• Experience20.03.2020-13.10.2023 Ondokuz Mayıs Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Doktor Öğretim Üyesimedicalpark.com.tr
• Experience19.08.2019-20.03.2020 Ondokuz Mayıs Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Öğretim Görevlisimedicalpark.com.tr
• Experience29.05.2014-14.03.2015 Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı Yoğun Bakım Bilim Dalı Yan Dal Araştırma Görevlisimedicalpark.com.tr
• Experience04.09.2009-21.11.2013 Kocaeli Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Araştırma Görevlisimedicalpark.com.tr

Education

• EducationMarmara Üniversitesi Tıp Fakültesi İngilizcemedicalpark.com.tr
• 20092013 Kocaeli Üniversitesi Tıp fakültesi Göğüs Hastalıkları İhtisasmedicalpark.com.tr
• 20202024 Ondokuz Mayıs Üniversitesi Tıp Fakültesi Göğüs Hastalıklarımedicalpark.com.tr

• Area of workCOVID-19Extracted from 3 publications · Model version —From source
• Publications48 publicationsORCID, OpenAlexFrom source
• ORCID0000-0001-8165-234XORCIDFrom source
• Last synchronised4 November 2026 20:35https://www.medicalpark.com.tr/hekimler/yusuf-taha-gullumedicalpark.com.tr

1. Right Ventricular Functional Improvement After Lung Transplantation and Adjunctive Pulmonary Rehabilitation: An Echocardiographic Analysis

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15020437 PMID 41598376 Open-access full textSource: ORCID

2. A Case of Lung Cancer Mimicking Invasive Pulmonary Aspergillosis in a Patient with Acute Myeloid Leukemia

   İç Hastalıkları Dergisi, 2025

   DOI 10.5578/ichastaliklari.20250327 Open-access full textSource: ORCID

3. Culture Positivity and Antibiotic Resistance in Respiratory Intensive Care Patients: Evaluation of Readmission and Clinical Outcomes

   Diagnostics, 2025

   DOI 10.3390/diagnostics15141737 PMID 40722487 Open-access full textSource: ORCID

4. Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?

   Diagnostics, 2025

   DOI 10.3390/diagnostics15131612 PMID 40647611 1 citation (Europe PMC) Open-access full textSource: ORCID

5. Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?

   2025

   DOI 10.20944/preprints202506.0191.v1 Open-access full textSource: ORCID

6. Investigation of pepsin levels in bronchial lavage in patients with interstitial lung disease and chronic cough

   Respiratory Medicine, 2024

   DOI 10.1016/j.rmed.2024.107781 PMID 39182853 1 citation (Europe PMC) Source: ORCID

7. The Outcomes of COVID-19 Patients with ARDS Who Received High Flow Nasal Oxygen in Medical Wards Outside Intensive Care Units Under Supervision of Non-intensivists.

   Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, 2024

   DOI 10.18614/deutip.1345427 Open-access full textSource: ORCID

8. Clinical evaluation of patients with COVID-19 within the framework of comorbidities

   2024

   DOI 10.22541/au.170666189.95505361/v1 Open-access full textSource: ORCID

9. Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies

   Medical Mycology, 2024

   DOI 10.1093/mmy/myae036 PMID 38592958 2 citations (Europe PMC) Source: ORCID

10. Investigation of pepsin levels in bronchial lavage in patients with interstitial lung disease and chronic cough

    European Respiratory Journal, 2023

    DOI 10.1183/13993003.congress-2023.pa3451 Source: OpenAlex